Hua Shan
Direktor/Vorstandsmitglied bei Tianjin Life Healthcare Clinical Laboratory Ltd.
Profil
Hua Shan is currently an Executive Director & Manager at Tianjin Life Healthcare Clinical Laboratory Ltd.
Prior to this, she worked as a Non-Executive Director at King International Investment Ltd.
from 2019 to 2020.
Ms. Shan holds an MBA from Tsinghua University and a graduate degree from Southwest Jiaotong University and Southwest University of Political & Law.
Aktive Positionen von Hua Shan
Unternehmen | Position | Beginn |
---|---|---|
Tianjin Life Healthcare Clinical Laboratory Ltd.
Tianjin Life Healthcare Clinical Laboratory Ltd. Financial ConglomeratesFinance Tianjin Life Healthcare Clinical Laboratory Ltd. engages in the development, consulting, service and transfer of biomedical technology. Its professions include clinical laboratory & immunology, serology and clinical cell molecular genetics. The company was founded on October 20, 2016 and is headquartered in Tianjin, China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Hua Shan
Unternehmen | Position | Ende |
---|---|---|
KING INTERNATIONAL INVESTMENT LIMITED | Vorstandsvorsitzender | 08.11.2019 |
Ausbildung von Hua Shan
Tsinghua University | Masters Business Admin |
Southwest Jiaotong University | Graduate Degree |
Southwest University of Political & Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KING INTERNATIONAL INVESTMENT LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Tianjin Life Healthcare Clinical Laboratory Ltd.
Tianjin Life Healthcare Clinical Laboratory Ltd. Financial ConglomeratesFinance Tianjin Life Healthcare Clinical Laboratory Ltd. engages in the development, consulting, service and transfer of biomedical technology. Its professions include clinical laboratory & immunology, serology and clinical cell molecular genetics. The company was founded on October 20, 2016 and is headquartered in Tianjin, China. | Finance |